<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04812132</url>
  </required_header>
  <id_info>
    <org_study_id>TartuUH</org_study_id>
    <nct_id>NCT04812132</nct_id>
  </id_info>
  <brief_title>RCT Comparing OAGB and Long Limb Roux Gastric Bypass</brief_title>
  <acronym>OAGBvsLLbypass</acronym>
  <official_title>A Multicentre Randomized Controlled Trial Comparing Outcome of Laparoscopic One-anastomosis Gastric Bypass and Laparoscopic Long Biliopancreatic Limb Roux Gastric Bypass for Treatment of Morbid Obesity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tartu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>North Estonia Medical Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fertilitas (private clinic)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tartu University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective multicenter randomized controlled trial to compare the outcomes of&#xD;
      one-anastomosis gastric bypass to long biliary limb Roux gastric bypass.&#xD;
&#xD;
      We plan to enroll up to 500 patients from three different clinics in Estonia. Outcomes are&#xD;
      excess weight loss %, impact on type 2 diabetes, hypertension, hyperlipidemia and obstructive&#xD;
      sleep apnea.&#xD;
&#xD;
      Other outcomes are nutritional deficiencies, occurrence of reflux disease and impact on&#xD;
      quality of life.&#xD;
&#xD;
      There are planned outpatient visits 1, 5 and 10 years after the surgery to measure the&#xD;
      impacts.&#xD;
&#xD;
      There are a lot of studies comparing OAGB to standard Roux gastric bypass but non comparing&#xD;
      it to long biliary limb gastric bypass.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2036</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2031</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Excess weight loss %</measure>
    <time_frame>10 years</time_frame>
    <description>Calculated loss of the excess weight</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact on type 2 diabetes mellitus</measure>
    <time_frame>10 years</time_frame>
    <description>Outcome of type 2 diabetes mellitus after the surgery, measured in change in HbA1c %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact on type 2 diabetes mellitus</measure>
    <time_frame>10 years</time_frame>
    <description>Outcome of type 2 diabetes mellitus after the surgery, measured in usage of medication (same dosage, decreased dosage, insulin to peroral, ended all medication)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact on hypertensive disease</measure>
    <time_frame>10 years</time_frame>
    <description>Outcome of hypertensive disease after the surgery; measured in antihypertensive drug usage (same, decrease, ended)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact on total cholesterol</measure>
    <time_frame>10 years</time_frame>
    <description>Outcome of hyperlipidemias after the surgery, measured in change in levels of total cholesterol (mmol/L).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact on hyperlipidemia</measure>
    <time_frame>10 years</time_frame>
    <description>Outcome of hyperlipidemias after the surgery, measured in change in levels of HDL (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact on hyperlipidemia</measure>
    <time_frame>10 years</time_frame>
    <description>Outcome of hyperlipidemias after the surgery, measured in change in levels of LDL (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact on hyperlipidemia</measure>
    <time_frame>10 years</time_frame>
    <description>Outcome of hyperlipidemias after the surgery, measured in change in levels of triglycerides (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact on hyperlipidemias</measure>
    <time_frame>10 years</time_frame>
    <description>Outcome of hyperlipidemias after the surgery, measured in change in levels of total cholesterol, HDL,LDL and triglycerides</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nutritional deficiencies: anemia</measure>
    <time_frame>10 years</time_frame>
    <description>% of subjects having hemoglobin below sex adjusted reference (g/L) and ferritin below sex adjusted references (ug/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional deficiencies</measure>
    <time_frame>10 years</time_frame>
    <description>Occurrence of B12 deficiency, measured in % of subjects with vitamin B12 below reference (measures in pmol/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GERD</measure>
    <time_frame>10 years</time_frame>
    <description>% of subjects reporting reflux disease symptoms and/or PPI usage after the surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Women</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Men</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One-anastomosis gastric bypass</intervention_name>
    <description>One group is planned to have one-anastomosis gastric bypass (also known as mini-bypass)</description>
    <arm_group_label>Men</arm_group_label>
    <arm_group_label>Women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Long biliary limb Roux gastric bypass</intervention_name>
    <description>Other group is planned to receive a long biliary limb Roux gastric bypass</description>
    <arm_group_label>Men</arm_group_label>
    <arm_group_label>Women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI over 35 and obesity related disease&#xD;
&#xD;
          -  BMI over 40&#xD;
&#xD;
          -  age between 18-60 years&#xD;
&#xD;
          -  agrees to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age under 18 years or over 60 years&#xD;
&#xD;
          -  abundant adhesions discovered during the surgery&#xD;
&#xD;
          -  active upper gastrointestinal ulcer disease&#xD;
&#xD;
          -  prior bariatric surgery&#xD;
&#xD;
          -  active symptomatic reflux disease&#xD;
&#xD;
          -  active psychiatric disease (eg psychosis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tartu University Hospital</name>
      <address>
        <city>Tartu</city>
        <zip>50406</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva-Maria Kikkas, Dr</last_name>
      <phone>+37258162720</phone>
      <email>evamariakikkas@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Toomas Sillakivi, Dr, PhD</last_name>
      <email>toomas.sillakivi@kliinikum.ee</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 27, 2021</study_first_submitted>
  <study_first_submitted_qc>March 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>March 21, 2021</last_update_submitted>
  <last_update_submitted_qc>March 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tartu University Hospital</investigator_affiliation>
    <investigator_full_name>Eva-Maria Kikkas</investigator_full_name>
    <investigator_title>Doctor and Teaching staff</investigator_title>
  </responsible_party>
  <keyword>OAGB</keyword>
  <keyword>Long biliary limb Roux gastric bypass</keyword>
  <keyword>Metabolic surgery</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

